Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00636233 · ClinicalTrials.gov registry record
Genetics of Spina Bifida and Anencephaly
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 10,000
- Enrollment target
NCT00636233: Completed study, sponsored by Duke University.
NCT00636233 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 10,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00636233 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 10,000 participants
- Enrollment target
Study Summary
The goal of this research study is to discover the genetic and environmental factors that contribute to the cause of neural tube defects such as spina bifida and anencephaly. Ultimately, this type of research may result in improved diagnosis, improved treatment and possibly prevention.
Primary Outcome
This study aims to discover genetic factors associated with neural tube defects such as anencephaly.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 1993-05 |
| Est. Completion | 2017-08-02 |
What the finished NCT00636233 record still lists
NCT00636233 is an observational study that tracks outcomes without assigning an intervention. Its 10,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00636233 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00636233 about?
NCT00636233 is a clinical study titled "Genetics of Spina Bifida and Anencephaly". The goal of this research study is to discover the genetic and environmental factors that contribute to the cause of neural tube defects such as spina bifida and anencephaly. Ultimately, this type of research may result in improved diagnosis, improved treatment and possibly prevention.
What is the current status of trial NCT00636233?
This trial is currently completed. The enrollment target is 10,000 participants. The study started on 1993-05. Estimated completion is 2017-08-02.
Who is sponsoring clinical trial NCT00636233?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00160771 · 10,000 participants
Biomechanics/Motion Analysis Laboratory Data Bank
- NCT00896935 · 10,000 participants
Arizona Cancer Center Biospecimen Repository
- NCT00898235 · 10,000 participants
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
- NCT00992303 · 10,000 participants
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia